HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of IV levetiracetam in children with acute repetitive seizures.

AbstractBACKGROUND:
Levetiracetam has been proven to be effective in both partial and generalized seizures in children. However, few studies have reported its efficacy in the treatment of acute repetitive seizures. We aimed to investigate the efficacy and safety of levetiracetam in children with acute repetitive seizures.
METHODS:
The medical records of children from the age of 1 month-18 years who received levetiracetam because of acute repetitive seizures in the pediatric intensive care unit between 2010 and 2013 were reviewed retrospectively.
RESULTS:
Of the 133 patients, levetiracetam terminated seizures in 104 (78.2%). Side effects such as agitation and aggression were observed in three patients (2.2%). The likelihood of treatment failure was increased by four times by younger age at seizure onset; by six times in the individuals with neurological abnormalities; and by 22 times in the patients with West syndrome. The patients who used levetiracetam as the first treatment option for acute repetitive seizures had a longer duration of epilepsy, a higher rate of neurological abnormality, and a higher proportion of medically resistant epilepsy compared with the individuals who used levetiracetam as an add-on treatment to the other intravenous antiepileptic drugs. However, no differences were detected between these two groups in terms of treatment response.
CONCLUSIONS:
Intravenous levetiracetam appears to be effective and safe in the treatment of acute repetitive seizures. Randomized clinical trials are needed to determine whether intravenous levetiracetam may replace other antiepileptic drugs as the first-line therapy in the management of acute repetitive seizures.
AuthorsRana İşgüder, Orkide Güzel, Hasan Ağın, Ünsal Yılmaz, Sanem Eren Akarcan, Tanju Celik, Aycan Ünalp
JournalPediatric neurology (Pediatr Neurol) Vol. 51 Issue 5 Pg. 688-95 (Nov 2014) ISSN: 1873-5150 [Electronic] United States
PMID25172096 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Anticonvulsants
  • Levetiracetam
  • Piracetam
Topics
  • Adolescent
  • Anticonvulsants (administration & dosage)
  • Child
  • Child, Preschool
  • Electroencephalography
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Infant, Newborn
  • Injections, Intravenous
  • Levetiracetam
  • Magnetic Resonance Imaging
  • Male
  • Piracetam (administration & dosage, analogs & derivatives)
  • ROC Curve
  • Retrospective Studies
  • Seizures (classification, drug therapy)
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: